Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Nivolumab in combination with R-CHOP for treatment-naïve diffuse large B-cell lymphoma: an evaluation of safety and efficacy.
Journal: Blood advances
Published: February 24, 2025
A Phase II Trial of Bevacizumab in Patients with Recurrent/Progressive Solid Tumor Brain Metastases That Have Progressed Following Whole-Brain Radiation Therapy.
Journal: Cancers
Published: April 30, 2024
Ibrutinib maintenance after frontline treatment in patients with mantle cell lymphoma.
Journal: Blood advances
Published: July 19, 2023
Efficacy and safety of tivozanib in recurrent, platinum-resistant ovarian, fallopian tube or primary peritoneal cancer, an NCCN phase II trial.
Journal: Gynecologic oncology
Published: April 29, 2021
Phase II study of pembrolizumab and capecitabine for triple negative and hormone receptor-positive, HER2-negative endocrine-refractory metastatic breast cancer.
Journal: Journal for immunotherapy of cancer
Published: January 16, 2020
Epidemiology of Anal Canal Cancer.
Journal: Surgical oncology clinics of North America
Published: November 28, 2016
Status of targeted therapies in the adjuvant treatment of colon cancer.
Journal: Journal of gastrointestinal oncology
Published: May 02, 2013
Next generation of mammalian target of rapamycin inhibitors for the treatment of cancer.
Journal: Expert opinion on investigational drugs
Published: April 03, 2013
Afatinib: emerging next-generation tyrosine kinase inhibitor for NSCLC.
Journal: OncoTargets and therapy
Published: March 16, 2013
Pathological complete response after neoadjuvant therapy for rectal cancer and the role of adjuvant therapy.
Journal: Current oncology reports
Published: February 06, 2013
Paradigm of polyendocrine therapy in endocrine responsive breast cancer: the role of fulvestrant.
Journal: Chinese clinical oncology
Published: August 10, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026